4701 Montgomery Boulevard NE, Albuquerque, NM, 87109 · (505) 727-7805
Beds
162
FY 2025
Star rating
4 of 5
Patient survey: 2 of 5
Net patient revenue
$242.5M
FY 2025
Net income
$54.4M
Patient care margin 17.6%
Discharges
9,103
Occupancy 49.4%
Clinicians
442
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $242.5M | $199.9M | 17.6% | $54.4M | 9,103 | $3.1M | 8.1% | 2.4% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart failure patients | 9.4% | US median 11% |
| Hospital-wide death rate within 30 days | 3.5% | US median 3.9% |
| Death rate for pneumonia patients | 13.1% | US median 15.2% |
| Death rate for stroke patients | 11.9% | US median 11.6% |
| Readmission rate for COPD | 19.1% | US median 19.8% |
| Readmission rate for heart failure | 20.5% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $205.8M | $181.1M | 12.0% | $28.6M | 6,288 | $2.6M | 8.0% | 2.4% |
| 2023 | $198.8M | $183.2M | 7.8% | $19.7M | 6,799 | $1.6M | 8.9% | 2.6% |
| 2022 | $195.4M | $178.7M | 8.6% | $21.3M | 6,840 | $1.4M | 8.3% | 3.2% |
| 2021 | $205.4M | $181.4M | 11.7% | $37.3M | 7,346 | $1.6M | 7.9% | 5.1% |
| 2020 | $188.0M | $161.8M | 13.9% | $34.7M | 6,937 | $2.2M | 9.3% | 4.1% |
| US median 21.3% |
| Readmission rate after hip or knee replacement | 5.6% | US median 5.8% |
| Readmission rate for pneumonia | 16.3% | US median 17.2% |
| Serious complications (patient safety composite) | 0.92 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.40 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.59 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 1.22 | US median 0.40 |
| Doctors always communicated well | 72% | US median 79% |
| Nurses always communicated well | 72% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 56% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 61% | US median 72% |
| Room and bathroom always clean | 59% | US median 73% |
| Patients who would definitely recommend the hospital | 65% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 205 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 7% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 71% | US median 65% |
| Healthcare workers given the flu vaccine | 95% | US median 79% |
| 19 |
| $53,610.05 |
| $8,262.00 |
| $10,022.34 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 18 | $78,310.11 | $10,225.11 | $12,667.88 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 16 | $65,587.38 | $5,882.63 | $7,681.44 |
| DRG 661 KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC | 14 | $80,260.21 | $6,113.50 | $6,873.22 |
| DRG 660 KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC | 13 | $89,505.23 | $8,478.62 | $9,721.70 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 12 | $100,518.42 | $10,384.17 | $13,076.55 |
| DRG 683 RENAL FAILURE WITH CC | 11 | $48,633.91 | $5,041.64 | $6,629.69 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 11 | $128,804.73 | $12,336.91 | $14,289.25 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5375 Level 5 Urology and Related Services | 161 | 156 | $3,557.22 | $3,917.51 |
| APC 5361 Level 1 Laparoscopy and Related Services | 137 | 136 | $3,979.92 | $4,357.80 |
| APC 5431 Level 1 Nerve Procedures | 101 | 87 | $1,361.53 | $1,406.61 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 92 | 82 | $1,090.64 | $1,219.56 |
| APC 5115 Level 5 Musculoskeletal Procedures | 78 | 76 | $9,742.25 | $10,771.69 |
| APC 5362 Level 2 Laparoscopy and Related Services | 59 | 59 | $7,220.83 | $8,164.45 |
| APC 5374 Level 4 Urology and Related Services | 55 | 51 | $2,413.06 | $2,629.24 |
| APC 5091 Level 1 Breast/Lymphatic Surgery and Related Procedures | 54 | 52 | $2,687.92 | $2,930.15 |
| APC 5414 Level 4 Gynecologic Procedures | 52 | 52 | $2,162.22 | $2,389.24 |
| APC 8011 Comprehensive Observation Services | 46 | 45 | $1,929.42 | $2,090.36 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 42 | 42 | $4,505.46 | $4,981.95 |
| APC 5302 Level 2 Upper GI Procedures | 40 | 34 | $1,328.88 | $1,444.50 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. | 3 | $59K |
| Biosense Webster, Inc. JNJ | 13 | $17K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Lovelace Women's Hospital is a for-profit short-term acute care hospital in Albuquerque, NM with 162 beds, part of Ardent Health and a 4-star overall rating.
Lovelace Women's Hospital in Albuquerque, NM has 162 beds (fiscal year 2025 cost report); 120 beds are certified for Medicare. It discharged 9,103 inpatients that year, with 49.4% of its beds in use on average.
In fiscal year 2025 (ending 2025-04-30), Lovelace Women's Hospital reported net patient revenue of $242.5M and operating expenses of $199.9M, a margin on patient care of 17.6%. After other income and expenses its net income was $54.4M (21.4% of revenue), so it made a profit that year.
Lovelace Women's Hospital is part of Ardent Health (listed company, ticker ARDT), a health system with 28 hospitals based in Brentwood, TN. It is a for-profit hospital.
Lovelace Women's Hospital has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, Lovelace Women's Hospital provides emergency services.
442 Medicare clinicians list Lovelace Women's Hospital as a hospital they work at, most often in Nurse Practitioner, Certified Registered Nurse Anesthetist (Crna), Physician Assistant.
In 2024, Lovelace Women's Hospital had 195 Medicare inpatient stays in 10 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 58 stays; Medicare paid $11,099.02 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $76K in payments to Lovelace Women's Hospital as a teaching hospital ($17K general and $59K for research) from 2 companies.